Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lacticaseibacillus rhamnosus GR-1® and Limosilactobacillus reuteri RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1® and RC-14® to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid and enhances probiotic bacterial survival to the lower intestine.
About Fem-Dophilus® 1 – Billion CFU:
For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional. If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.
Fem-Dophilus ® does not require refrigeration and best to store in cool, dry place. Avoid storage at temperature above 77°F (25°C). Refrigeration, however, extends shelf life.
NOTE:
Serving Size: 1 Capsule |
||
|
Amount Per Serving |
%DV |
Proprietary Probiotic Blend |
134 mg (1 Billion CFU) |
†† |
Lacticaseibacillus rhamnosus GR-1® |
|
|
Limosilactobacillus reuteri RC-14® |
|
|
†† Daily Value (DV) not established. |
||
Other Ingredients: Maltodextrin, capsule (hydroxy-propylmethylcellulose, titanium dioxide [color]), microcrystalline cellulose and magnesium stearate (vegetable source). No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/ tree nuts. Free of major allergens. |
The goal of Jarrow Formulas® is to promote optimal health with high-quality, effective, affordable, and superior formulation of dietary supplements. Their staff of scientists and health professionals are actively involved in clinical studies and continually work with researchers to provide the best service and technical information to consumers.